Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

The 10 most talked-about journal articles about Alzheimer’s Disease

Posted on August 2nd, 2016 by in Pharma R&D

The Alzheimer’s Association International Conference just wrapped up in Toronto, Canada (Patrick May was there and will be writing all about it). In honor of the conference, here is a list of Alzheimer’s-related journal articles that were most-talked about in the last month in social media, blogs, and news coverage. Continue reading “The 10 most talked-about journal articles about Alzheimer’s Disease” »

PV Poll: Processing of EMA MLM Data

Posted on March 16th, 2016 by in Pharmacovigilance

Over the past few months, we have posted blog entries about the EMA Medical Literature Monitoring (MLM) program, including a review of the EMA Annual Update and impressions of the launch phase closure report. Continue reading “PV Poll: Processing of EMA MLM Data” »

EMA’s Medical Literature Monitoring: Shakedown or Shakeup

Posted on October 27th, 2015 by in Pharmacovigilance

Although, quite a lot of existing flows have to change and new ones have to be implemented, there are, also, quite a lot of benefits, most of them for EMA, and some, not so obvious, for the MAH’s. Of these last ones, many are found by looking at the information, now made available by EMA, as an information professional in a pharmacovigilance context, as well as a pharmacovigilance analyst in an information rich environment.

Read more about EMA’s Medical Literature Monitoring